Elective laparoscopic colectomy in a patient 3 weeks after coronavirus disease 2019 infection: a case report

Tateno, Yuki; Harada, Kimito; Okamoto, Fumiki; Katsuragawa, Hideo

doi:10.1186/s13256-021-02877-4

Cited by 3 publications

(7 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our review, males gender predominated development of SARS-CoV-2 illness in CRC patients, a finding suggested in most of the reports [ 9 , 11 , 14 , 16 , 17 , 25 , 27 , 28 , 30 , 32 – 35 , 47 , 52 – 59 , 61 , 62 , 71 , 72 , 74 , 75 , 77 , 81 – 85 ] and in contradiction with data from other reports suggesting an equal proportion of COVID-19 cases in CRC patients for both genders [ 14 , 23 , 29 , 31 , 60 , 80 ] or patients with CRC and SARS-CoV-2 illness were mostly females [ 11 , 36 , 46 , 49 , 50 , 66 , 67 , 76 ]. This review reflects previous studies in showing that the overall incidence of CRC is higher in males than in females [ 99 – 101 ].…”

Section: Discussionsupporting

confidence: 57%

“…The detailed characteristics of the included studies are shown in Table 1 . There were 16 case report [ 16 , 32 , 46 , 48 – 50 , 52 , 54 , 55 , 59 , 66 , 67 , 71 , 75 , 82 , 84 ], 9 case series, 41 cohort [ 8 – 17 , 23 , 25 , 26 , 29 , 31 , 34 , 43 – 45 , 51 , 53 , 56 – 58 , 60 – 65 , 68 – 70 , 73 , 74 , 77 , 79 , 80 , 83 , 85 ], 2 cross-sectional [ 72 , 76 ] and 1 case–control [ 81 ] studies. These studies were conducted in China ( n = 15), Italy ( n = 8), United States ( n = 6), United Kingdom ( n = 6), Spain ( n = 5), India ( n = 4), France ( n = 3), Turkey ( n = 2), Brazil ( n = 2), Japan ( n = 2), Colombia ( n = 1), Philippines ( n = 1), Poland ( n = 1), Iran ( n = 1), The Netherlands ( n = 1), Belgium ( n = 1), United Arab Emirates ( n = 1), Mexico ( n = 1), Sweden ( n = 1), Austria ( n = 1), Hungary ( n = 1), Australia ( n = 1), and Chile ( n = 1).…”

Section: Resultsmentioning

confidence: 99%

“…The median patient age ranged from 51.6 years to 80 years across studies. There was an increased male predominance in CRC patients diagnosed with SARS-CoV-2 in most of the studies [ n = 2243, 66.7%] [ 9 , 11 , 14 , 16 , 17 , 25 , 27 , 28 , 30 , 32 – 35 , 47 , 52 – 59 , 61 , 62 , 71 , 72 , 74 , 75 , 77 , 81 – 85 ] and majority of the patients belonged to White (Caucasian) ( n = 262, 7.8%), Hispanic ( n = 156, 4.6%) and Asian ( n = 153, 4.5%) ethnicity [ 11 , 13 – 17 , 25 – 34 , 36 , 43 , 44 , 46 – 50 , 52 – 55 , 57 – 61 , 67 , 70 – 73 , 75 – 78 , 80 , 81 , 83 – 85 ]. Most patients were diagnosed for CRC through symptoms, endoscopy, radiological imaging, biopsies and tumor markers [ 8 – 10 , 12 – 14 , 16 , 17 , 23 , 25 – 36 , 43 , 44 , 46 – 56 , 58 – 61 , 65 – 77 ...…”

Section: Resultsmentioning

confidence: 99%

“…Most patients were diagnosed for CRC through symptoms, endoscopy, radiological imaging, biopsies and tumor markers [ 8 – 10 , 12 – 14 , 16 , 17 , 23 , 25 – 36 , 43 , 44 , 46 – 56 , 58 – 61 , 65 – 77 , 80 – 85 ]. The main source of SARS-CoV-2 infection in CRC patients was community-acquired ( n = 2882, 85.7%; p = 0.014) [ 8 , 11 – 17 , 23 , 28 , 29 , 33 , 34 , 43 – 45 , 48 , 50 , 52 , 55 , 58 , 59 , 62 – 67 , 70 , 71 , 75 , 76 , 81 – 83 ]. Most of those SARS-CoV-2 patients had stage III CRC ( n = 725, 21.6%; p = 0.036) [ 9 , 13 , 17 , 35 , 45 , 72 , 83 ]; and were treated mainly with surgical resections ( n = 304, 9%) and chemotherapies ( n = 187, 5.6%), p = 0.008 [ 9 – 11 , 16 , 17 , 23 , 25 , 26 , 28 , 29 , 31 – 36 , 43 – 45...…”

Section: Resultsmentioning

confidence: 99%

“…The most common tumor symptoms patients experienced were change in bowel habits ( n = 26, 0.8%), diarrhoea ( n = 25, 0.7%), abdominal pain ( n = 23, 0.7%), and nausea and vomiting ( n = 21, 0.6%); p = 0.048 [ 11 , 16 , 17 , 27 , 46 , 50 , 55 , 58 , 61 , 70 , 72 , 81 ]. Many of the CRC patients infected with COVID-19 had pre-existing hypertension ( n = 68, 2%) and/or diabetes mellitus ( n = 49, 1.4%), p = 0.027 [ 11 , 17 , 28 , 31 , 33 , 34 , 44 , 46 , 55 , 57 , 58 , 61 , 62 , 71 , 72 , 74 , 75 , 77 , 79 , 80 , 83 , 85 ].…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis

Alhumaid

Mutair

Busubaih

et al. 2022

Infect Agents Cancer

View full text Add to dashboard Cite

Background Patients with colorectal cancer (CRC) are more likely to develop severe course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and experience increased risk of mortality compared to SARS-CoV-2 patients without CRC. Objectives To estimate the prevalence of SARS-CoV-2 infection in CRC patients and analyse the demographic parameters, clinical characteristics and treatment outcomes in CRC patients with COVID-19 illness. Methods For this systematic review and meta-analysis, we searched Proquest, Medline, Embase, Pubmed, CINAHL, Wiley online library, Scopus and Nature for studies on the incidence of SARS-CoV-2 infection in CRC patients, published from December 1, 2019 to December 31, 2021, with English language restriction. Effect sizes of prevalence were pooled with 95% confidence intervals (CIs). Sub-group analyses were performed to minimize heterogeneity. Binary logistic regression model was used to explore the effect of various demographic and clinical characteristics on patient’s final treatment outcome (survival or death). Results Of the 472 papers that were identified, 69 articles were included in the systematic review and meta-analysis (41 cohort, 16 case-report, 9 case-series, 2 cross-sectional, and 1 case-control studies). Studies involving 3362 CRC patients with confirmed SARS-CoV-2 (all patients were adults) were analyzed. The overall pooled proportions of CRC patients who had laboratory-confirmed community-acquired and hospital-acquired SARS-CoV-2 infections were 8.1% (95% CI 6.1 to 10.1, n = 1308, 24 studies, I2 98%, p = 0.66), and 1.5% (95% CI 1.1 to 1.9, n = 472, 27 studies, I2 94%, p < 0.01). The median patient age ranged from 51.6 years to 80 years across studies. The majority of the patients were male (n = 2243, 66.7%) and belonged to White (Caucasian) (n = 262, 7.8%), Hispanic (n = 156, 4.6%) and Asian (n = 153, 4.4%) ethnicity. The main source of SARS-CoV-2 infection in CRC patients was community-acquired (n = 2882, 85.7%; p = 0.014). Most of those SARS-CoV-2 patients had stage III CRC (n = 725, 21.6%; p = 0.036) and were treated mainly with surgical resections (n = 304, 9%) and chemotherapies (n = 187, 5.6%), p = 0.008. The odd ratios of death were significantly high in patients with old age (≥ 60 years) (OR 1.96, 95% CI 0.94–0.96; p < 0.001), male gender (OR 1.44, 95% CI 0.41–0.47; p < 0.001) CRC stage III (OR 1.54, 95% CI 0.02–1.05; p = 0.041), CRC stage IV (OR 1.69, 95% CI 0.17–1.2; p = 0.009), recent active treatment with chemotherapies (OR 1.35, 95% CI 0.5–0.66; p = 0.023) or surgical resections (OR 1.4, 95% CI 0.8–0.73; p = 0.016) and admission to ICU (OR 1.88, 95% CI 0.85–1.12; p < 0.001) compared to those who survived. Conclusion SARS-CoV-2 infection in CRC patient is not uncommon and results in a mortality rate of 26.2%. Key determinants that lead to increased mortality in CRC patients infected with COVID-19 include older age (≥ 60 years old); male gender; Asian and Hispanic ethnicity; if SARS-CoV-2 was acquired from hospital source; advanced CRC (stage III and IV); if patient received chemotherapies or surgical treatment; and if patient was admitted to ICU, ventilated or experienced ARDS.

show abstract

Section: Discussionsupporting

confidence: 57%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis

Alhumaid

Mutair

Busubaih

et al. 2022

Infect Agents Cancer

View full text Add to dashboard Cite

show abstract

Post-Acute COVID-19 Syndrome for Anesthesiologists: A Narrative Review and a Pragmatic Approach to Clinical Care

Kopanczyk

Kumar

Papadimos

2022

Journal of Cardiothoracic and Vascular Anesthesia

View full text Add to dashboard Cite

Post-acute coronavirus disease 2019 (COVID-19) syndrome is a novel, poorly understood clinical entity with life-impacting ramifications. Patients with this syndrome, also known as “ COVID-19 long-haulers ,” often present with non-specific ailments involving more than one body system. The most common complaints include dyspnea, fatigue, brain fog, and chest pain. There is currently no single agreed-upon definition for post-acute COVID-19 syndrome, but most agree that criterion for this syndrome is the persistence of mental and physical health consequences after initial infection. Given the millions of acute infections in the U.S. over the course of the pandemic, perioperative providers will encounter these patients in clinical practice in growing numbers. Symptoms of the COVID-19 long-haulers should not be minimized as these patients are at higher risk for postoperative respiratory complications and perioperative mortality for up to 7 weeks after initial illness. Instead, a cautious multidisciplinary preoperative evaluation should be performed. Perioperative care should be viewed through the prism of best practices already in use such as avoidance of benzodiazepines in patients with cognitive impairment and use of lung protective ventilation. Recommendations especially relevant to the COVID-19 long-haulers include assessment of critical care myopathies and neuropathies to determine suitable neuromuscular blocking agents and reversal, preoperative workup of insidious cardiac or pulmonary pathologies in previously healthy patients, and thorough medication review, particularly of anticoagulation regimens and chronic steroid use. In this article, we define the syndrome, synthesize the available scientific evidence, and make pragmatic suggestions regarding the perioperative clinical care of COVID-19 long-haulers.

show abstract

Short-Term Outcomes of Laparoscopic-Assisted Colectomy versus Open Colectomy in Patients with Colonic Carcinoma: A Prospective Randomized Study

Baz

Orban

Ezzat

2023

Journal of Coloproctology

View full text Add to dashboard Cite

Introduction The second most common cause of cancer-related mortality is colorectal cancer, and laparoscopic-assisted colectomy (LAC) has gained popularity among surgeons as an alternative to the conventional approach, which is open colecrtomy (OC). The differences between LAC and OC in terms of short-term outcomes have not been well documented, and the aim of the present work is to compare the short-term outcomes of both procedures. Materials and Methods The present prospective study comprised 164 participants submitted to LAC (n = 82) and OC (n = 82) at the Helwan and Zagazig University hospitals between January 2018 and January 2022. We collected and analyzed demographic data, surgical data, and the short-term outcomes. Results The LAC group had a significantly lower estimated amount of blood loss, shorter hospital stay, lower rates of incisional surgical site infection, and fewer cases of burst abdomen postoperatively, but with a considerably longer operative time (30.3 minutes) than the OC group. Conclusions Our findings show that LAC is favorable option to OC, with superior outcomes.

show abstract

Elective laparoscopic colectomy in a patient 3 weeks after coronavirus disease 2019 infection: a case report

Cited by 3 publications

References 11 publications

Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis

Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis

Post-Acute COVID-19 Syndrome for Anesthesiologists: A Narrative Review and a Pragmatic Approach to Clinical Care

Short-Term Outcomes of Laparoscopic-Assisted Colectomy versus Open Colectomy in Patients with Colonic Carcinoma: A Prospective Randomized Study

Contact Info

Product

Resources

About